Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · IEX Real-Time Price · USD
2.130
+0.080 (3.90%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Checkpoint Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CKPT stock have an average target of 22.6, with a low estimate of 4.00 and a high estimate of 47. The average target predicts an increase of 961.03% from the current stock price of 2.13.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CKPT stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,496.24% | Jun 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,496.24% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,496.24% | Mar 22, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +87.79% | Dec 20, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +1,496.24% | Dec 19, 2023 |
Financial Forecast
Revenue This Year
47.43K
from 103.00K
Decreased by -53.95%
Revenue Next Year
48.76M
from 47.43K
Increased by 102,695.70%
EPS This Year
-1.26
from -3.17
EPS Next Year
-0.20
from -1.26
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 97,650 | 50.2M |
| Avg | 47,430 | 48.8M |
| Low | n/a | 46.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | -5.2% | 105,719.1% |
| Avg | -54.0% | 102,695.7% |
| Low | - | 98,664.5% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -1.30 | -0.21 |
| Avg | -1.26 | -0.20 |
| Low | -1.22 | -0.20 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.